论文信息 - One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study - 字舞流文

One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study

M. Bartels | B. Biemond | M. Cnossen | R. Schutgens | R. van Wijk | B. V. van Oirschot | E. Nur | A. Rijneveld | E. V. van Beers | J. Bos | M. V. van Dijk | Wouter W. Van Solinge | Minke A E Rab | C. Derichs | Judith J. M. Jans